# Impact of OCT1 and CYP2D6 Genotypes on Pharmacokinetics of Berberine in Healthy Volunteers

> **NCT05463003** · NA · COMPLETED · sponsor: **University Medicine Greifswald** · enrollment: 42 (actual)

## Conditions studied

- Pharmacokinetic Study in Healthy Volunteers

## Interventions

- **DIETARY_SUPPLEMENT:** Berberine

## Key facts

- **NCT ID:** NCT05463003
- **Lead sponsor:** University Medicine Greifswald
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-19
- **Primary completion:** 2022-11-20
- **Final completion:** 2022-12-31
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2024-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05463003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05463003, "Impact of OCT1 and CYP2D6 Genotypes on Pharmacokinetics of Berberine in Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05463003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*